We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Check the tariff classification for analytical methods for determining the fat, starch and protein content within Chapters 11 and 23.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
Find out if the goods you're declaring to inward or outward processing are classed as sensitive goods.
Intrahepatic cholestasis of pregnancy (ICP) has been rarely reported in patients treated with azathioprine products and is believed to be a risk applicable to all drugs in the thiopurine class (azathioprine, mercaptopurine and tioguanine). Cholestasis of pregnancy associated with thiopurines...
Volume 47 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Prospective cohort study
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).